Market Research Blog – Page 1113 – New Product Development

Central Venous Catheter Market to Reach USD 5,314.5 Million by 2033 at a 5.1% of CAGR

The global central venous catheters market is set to experience substantial growth over the next decade. According to our healthcare analysts, the market size is expected to achieve a valuation of USD 5,314.5 million by 2033, reflecting a compound annual growth rate (CAGR) of 5.1%.

Currently valued at USD 3,238.1 million in 2023, the market’s expansion is attributed to several factors, including advancements in medical technology, increasing prevalence of chronic diseases, and a rising number of surgical procedures that necessitate the use of central venous catheters.

Manufacturers in the central venous catheter industry can anticipate a steady growth trajectory, driven by continuous innovations and an increasing demand for high-quality medical devices. This growth presents lucrative opportunities for stakeholders and underscores the vital role of central venous catheters in modern healthcare.

Central venous catheters are vital to medical treatments because they allow for the administration of medications, fluids, and blood products, as well as the measurement of central venous pressure and hemodynamic monitoring. A variety of reasons, such as the growing need for minimally invasive procedures, the increasing incidence of chronic diseases, and advancements in catheter design and material, are projected to drive the growth of the central venous catheter market.

Parenteral nutrition, or intravenous nutrient infusion, is necessary for patients who are unable to acquire enough nutrients through oral or enteral means. This includes those who have had surgery, are receiving treatment for cancer, or have serious gastrointestinal disorders. As more people become aware of the significance of nutrition for both general health and patient rehabilitation, central venous catheters are becoming more and more required to deliver parenteral nutrition therapy.

Key Takeaways from the Central Venous Catheter Market Report:

In 2018, the global market size stood at US$ 2,446.9 million.
The market size developed at a 4.7% CAGR from 2018 to 2022.
In 2022, the global market size stood at US$ 3,074.7 million.
In 2022, the non-anti-microbial catheter segment garnered 75.7% of the central venous catheter market shares.
In 2022, the double lumen segment gained 63.6% of the central venous catheter market shares.
In 2022, the hospitals segment garnered 60.3% of the central venous catheter market shares.
The United Kingdom’s central venous catheter market will develop at a CAGR of 9.0% through 2033.
Germany’s central venous catheter market will rise at a 3.3% CAGR through 2033.
Australia’s central venous catheter market growth will thrive at a 5.1% CAGR through 2033.

Recent Developments Observed by FMI:

Coloplast unveiled a novel catheter in the United States in January 2023. The SpeediCath Flex Set catheter is intended for use by those with bladders and urine problems. Triple Action Coating Technology is a feature on all SpeediCath catheters designed to reduce the risk of urethral damage and urinary tract infections (UTIs) for patients with spinal cord injuries (SCI).
Braun Medical Inc. (B. Braun), a pioneer in infusion therapy, announced the launch of its new Introcan Safety 2 IV Catheter with one-time blood control in July 2022. The Introcan Safety 2 IV Catheter, the newest invention from B. Braun, makes IV access safer for the clinician by reducing the risk of blood exposure and needlestick accidents.

The CVC market is expected to continue growing as healthcare professionals strive to fulfill patients’ changing expectations and enhance clinical results. Central venous catheters are maturing into essential instruments in contemporary healthcare due to the convergence of cutting-edge technology, patient-centric design, and infection control measures. A dedication to innovation, regulatory compliance, and the search for cost-effective solutions for patients and healthcare systems underpin the market’s growth trajectory,” says an FMI analyst.

Competitive Landscape

A blend of international and regional businesses defines the central venous catheter (CVC) market’s competitive environment. Prominent multinational corporations with sizable market shares include Becton, Dickinson and Company (BD), Teleflex Inc., and C.R. Bard (now acquired by BD). These market leaders use their vast product portfolios, well-developed distribution systems, and strong R&D departments to keep a competitive edge.

Regional players are essential to supplying local markets at the same time. They frequently concentrate on specialized markets, personalization, and affordable fixes while taking into account particular regional tastes and healthcare needs. Global and regional firms frequently use partnerships, mergers, and acquisitions to increase their market share, gain access to new technology, and improve their product offerings.

Recent Developments

In January 2023, Coloplast introduced a new catheter in the United States. People with bladder and urine issues are the target market for the SpeediCath Flex Set catheter. All SpeediCath catheters have Triple Action Coating Technology, a choice for people with spinal cord injuries (SCI) and intended to lower the risk of urethral injury and urinary tract infections (UTIs).
A pioneer in infusion therapy, B. Braun Medical Inc. (B. Braun) announced the introduction of its new Introcan Safety 2 IV Catheter with one-time blood control in July 2022. The newest innovation from B. Braun makes IV access safer for the clinician by lowering the possibility of needlestick injuries and exposure to blood with the Introcan Safety 2 IV Catheter.

Key Players in the Central Venous Catheter Market:

Angio Dynamics
C.R. Bard
Teleflex Incorporated
B. Braun Melsungen AG
Kimal Healthcare
Come B.V.
Medtronic Plc
Smiths Medical
Vygon (UK) Ltd.
Becton, Dickinson, and Company
Argon Medical Devices Inc.
Boston Scientific Corporation
Cook Medical Incorporated
Medical Components Inc.
Fresenius Kabi AG

Central Venous Catheter Market Segmentation

By Product:

Dialysis Catheters
Acute Hemodialysis Catheter
Chronic Hemodialysis Catheter
Peritoneal Dialysis Catheter
PICC Catheters
Implantable Port
CVC Catheters
Tunneled Catheters
Non-tunneled Catheters

By Property:

Anti-microbial Catheter
Non-Anti-Microbial Catheter

By Design:

Single Lumen
Double Lumen
Multiple Lumen

By End-user:

Hospitals
Ambulatory Surgical Centers
Dialysis Centers
Specialty Clinics
Others

By Region:

North America
Latin America
Europe
South Asia
East Asia
Oceania
Middle East and Africa

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

North American Vision Care Market to Reach USD 114,800.8 Million by 2033 at a 5.8% of CAGR

The North American vision care market, with demand expected to rise at a compound annual growth rate (CAGR) of 5.8% through 2033. The market, currently valued at USD 65,326.3 million in 2023, is projected to expand to approximately USD 114,800.8 million by the end of the forecast period.

This notable growth trajectory reflects increasing consumer awareness about eye health, advancements in vision care technology, and a rising prevalence of vision-related issues. As the population ages and the need for effective eye care solutions intensifies, the demand for comprehensive vision care products and services is set to surge.

One of the key challenges in the industry is the high costs associated with advanced vision care treatments and procedures, limiting accessibility for a significant portion of the population. Additionally, the need for more awareness regarding the importance of regular eye check-ups and preventive measures among specific demographics has contributed to the underutilization of vision care services.

The growing adoption of teleophthalmology services and the integration of digital technologies offer avenues for expanding the reach of vision care services to remote and underserved areas. The rising consumer preference for customized vision care solutions and the increasing focus on value-based care models provide opportunities for market players to innovate and diversify their product offerings.

The integration of artificial intelligence and machine learning in vision diagnostics and treatment planning has revolutionized the sector, enabling more accurate diagnoses and personalized treatment regimens. The rising adoption of wearable vision care devices and the development of advanced nanotechnology-based treatment options are also emerging as prominent trends, shaping the future of the vision care industry in North America.

“The increasing focus on eco-friendly and sustainable vision care products has gained traction, with manufacturers emphasizing the use of biodegradable materials and eco-conscious production processes,” opines Sabyasachi Ghosh, Associate Vice President at Future Market Insights (FMI).

Key Takeaways from the North America Vision Care Market:

In 2023, Rx-Lenses dominate the market with a share of 47.1% in the North American vision care industry.
Retail Stores establish themselves as the foremost distribution channel in the North American vision care market, securing a significant market share of 61.2% in 2023.
Demand for vision care products in Canada exhibits a robust CAGR of 8.2%, expected to persist through 2033.
The United States showcases a vigorous demand for vision care products, with an impressive CAGR of 9.9% projected to endure until 2033.

Competition Outlook of North America Vision Care Market:

Key players operating in the vision care industry in North America compete through product diversification, technological advancements, and strategic collaborations to gain a competitive edge and expand their market share. Companies are focusing on enhancing their distribution networks and strengthening their brand presence to stay ahead in the industry.

Many leading players are investing heavily in research and development to introduce innovative products and technologies, catering to consumers’ diverse and evolving needs in the vision care sector. Strategic partnerships and mergers with local and international players enable companies to expand their geographic reach and offer comprehensive solutions to a broader customer base.

New entrants can capitalize on the growing demand for personalized and technologically advanced vision care solutions by introducing innovative products and services tailored to specific consumer segments. Investing in advanced manufacturing capabilities and distribution networks can help new players establish goodwill in the North America vision care industry.

North America Vision Care Market Recent Developments:

Alcon (Novartis) launches new PrecisionID technology for LASIK surgery. Alcon, a division of Novartis, has launched a new technology called PrecisionID for LASIK surgery. The new technology uses a laser to create a personalized 3D map of the patient’s eye, which is then used to guide the laser during surgery.
CooperVision launches new MiSight contact lenses for myopia control. CooperVision has launched a new line of contact lenses called MiSight. The new contact lenses are designed to slow the progression of myopia, or nearsightedness, in children.
Bausch & Lomb launches new ULTRA ONE DAY contact lenses. Bausch & Lomb has launched a new line of daily disposable contact lenses called ULTRA ONE DAY. The new contact lenses are designed to provide all-day comfort and moisture, and they also feature a UV filter to protect the eyes from the sun.
Warby Parker launches new Try-On program. Warby Parker, a direct-to-consumer eyewear company, has launched a new Try-On program. The new program allows customers to try on five pairs of glasses for five days at home before they buy.

Key Companies Providing North American Vision Care Market:

EssilorLuxottica
Johnson & Johnson Vision
Alcon (Novartis)
CooperVision
Bausch & Lomb
Warby Parker
LensCrafters
Visionworks
Pearle Vision
EyeBuyDirect
National Vision

A Full Report – Overview

North America Vision Care Market Key Segments:

By Product Type:

Rx-Lenses
Frames
Contact Lenses
Non-Rx Sunglasses
Reading Glasses
Contact Lens Solutions

By Distribution Channel:

Retail Stores
E-Commerce
Clinics

Author

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Prosthetic Heart Valve Market Expected to Reach USD 27,277.6 Million by 2033 at a 7.5% of CAGR

Future Market Insights forecasts robust growth for the global prosthetic heart valve market, which is projected to reach USD 13,234.9 million by 2023. The market is anticipated to advance significantly, with a valuation of USD 27,277.6 million by 2033.

The market’s expansion is driven by a compound annual growth rate (CAGR) of 7.5% over the forecast period, fueled by the increasing prevalence of valvular heart diseases such as tricuspid regurgitation, idiopathic and ischemic mitral regurgitation, and aortic stenosis.

When considering end users, hospitals took the lead in the global prosthetic heart valve market in 2021, commanding an estimated revenue share exceeding 75%. This dominance is expected to persist throughout the forecast period

According to Future Market Insights, an increasing prevalence of valvular heart disease (VHD) is expected to augment the growth of the global prosthetic heart valve market during the forecast period. Regulatory approval for heart valves, integration of technological advancements, and an increasing number of heart valve implantation procedures are other factors expected to influence the revenue growth of the global prosthetic heart valve market in the next 10 years. However, high costs associated with transcatheter heart valve products, procedure-related risks and complications, and product recalls are some restraints likely to hamper the growth of the global prosthetic heart valve market over the forecast period.

Segmentation highlights

The global prosthetic heart valve market is segmented on the basis of Product Type (Mechanical Heart Valves, Biological/Tissue Heart Valves, Transcatheter Heart Valves) and End User (Hospitals, Ambulatory Surgery Centres).

The Transcatheter Heart Valves product type segment is estimated to be valued at US$ 6,069.1 Mn by 2026 end, registering a CAGR of 13.3% between 2016 and 2026
The Hospitals end user segment accounted for 74.5% market share of the global prosthetic heart valve market in 2015. Rising demand for quicker treatment options and remedies is expected to promote the revenue growth of the Hospitals segment over the forecast period

Regional market projections

The global prosthetic heart valve market is segmented by region into North America, Latin America Excluding Brazil, Brazil, Western Europe, Eastern Europe, Asia Pacific Excluding Japan (APEJ), and Middle East & Africa (MEA). The global prosthetic heart valve market is largely prominent in the developed regions.

The North America regional market is estimated to witness the highest CAGR of 12.4% during the forecast period followed by the Western Europe regional market at 12.1%. Factors such as legislative openness and inline approval procedures are expected to contribute largely to the revenue generation potential and attractiveness of the Western Europe prosthetic heart valve market. Rising adoption of transcatheter heart valves in geriatric patients for better care is expected to fuel revenue growth in the Japan prosthetic heart valve market over the forecast period.

Vendor insights

The report on the global prosthetic heart valve market profiles some of the leading companies dominating the global prosthetic heart valve market. Top market players featured in the global prosthetic heart valve market report are Edwards Lifesciences Corporation, St. Jude Medical, Inc., Medtronic plc, Boston Scientific Corporation, Abbott Laboratories, SYMETIS, LivaNova PLC, CryoLife, Inc., Braile Biomedica, Colibri Heart Valve LLC, and JenaValve Technology, Inc. Leading market players are focussing on delivering differentiated therapies to cardiac patients and are strengthening their foothold in the global prosthetic heart valve market through strategic collaborations and acquisitions.

Key competitors covered in terms of prosthetic heart valve market are Edwards Lifesciences Corporation, St. Jude Medical, Inc., Medtronic plc, Boston Scientific Corporation, Abbott Laboratories, SYMETIS, LivaNovaPLC, CryoLife, Inc., Braile Biomedica, Colibri Heart Valve, LLC, and JenaValve Technology, Inc.

Key strategies adopted by most of the major players in the global prosthetic heart valve market include:

product approvals and commercialisation, leveraging existing capabilities to create patient-centric technologies, briskly entering markets in emerging countries and offering the latest innovative technologies to healthcare facilities and, thus strengthening regional proficiency and addressing customer needs. New product launches, innovation and expansion are anticipated to form the core of these strategies during the forecast period.

A Full Report – Overview

Key Segment

By Product Type

Mechanical Heart Valves
Mechanical Aortic Valve
Mechanical Mitral Valve
Biological/Tissue Heart Valves
Tissue Aortic Valve
Tissue Mitral Valve
Transcatheter Heart Valves
Transcatheter Aortic Valve
Transcatheter Mitral Valve

By End User

Hospitals
Ambulatory Surgery Centres

About Future Market Insights (FMI)

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Coronary Stents Market Growth to Reach USD 51.2 Billion by 2032, Growing at a 5.1% CAGR

The fight against heart disease is gaining momentum with advancements in coronary stents. The global Coronary Stents Market is projected to reach a substantial USD 51.2 billion by 2032, reflecting a steady growth trajectory. This translates to a projected Compound Annual Growth Rate (CAGR) of 5.1% from 2022 to 2032. In 2022, the market was valued at an estimated USD 33.36 billion.

The increasing awareness of the manifold benefits associated with stenting procedures, such as the significant enhancement of blood flow and protection against further damage to the heart muscle, is a pivotal driver of market expansion. Stenting also offers a means to ameliorate heart disease symptoms, including angina and shortness of breath, ultimately reducing the necessity for coronary bypass surgery. Consequently, both surgeons and patients, given its minimally invasive nature and relatively brief post-operative recovery period, favor stenting.

Furthermore, a rise in the global geriatric population is leading to a larger patient pool with serious cardiovascular diseases. Again, hypertension is arising as a grave public health concern. Obesity, too, adds to this burden as one of the primary risk factors accountable for different cardiovascular diseases worldwide.

Coronary stenting is prescribed to patients who are suffering from coronary artery blockage. Though angioplasty is the first line of treatment for patients with acute coronary artery blockages the number of patients undergoing stenting has been increasing steadily over the last ten years. This is owing to the rise of outpatient coronary stenting procedures, which shortens long hospital stays. Additionally, a large number of cardiologists prescribing stenting procedures for patients with CAD is a prime factor that will likely fuel revenue growth of the coronary stent market during the forecast period.

“Increasing cases of lifestyle diseases like obesity and diabetes often result in heart issues which, in turn, supplements the global growth of the coronary stents market over the forecast period,” says an FMI analyst.

Coronary Stents Market Key Takeaways:

Rising awareness of the benefits associated with stenting will strengthen market prospects.
Prevalence of alternative treatment methods, product failure, and recalls are certain factors that may hamper market growth.
Growing cases of coronary artery diseases propel the coronary stent market in the United States.
Favorable government support for the healthcare sector will present new market opportunities in China.

Coronary Stents Market Competitive Landscape

Abbott, Medtronic, Boston Scientific Corporation, Terumo Corporation, B Braun Melsungen AG, Biotronik, Stentys SA, MicroPort Scientific Corporation, C. R. Bard, Inc., and Cook Medica among others are some of the major players in the coronary stents market profiled in the full version of the report.

Key market players are focusing on product upgrades and offering new features to meet the rising consumer demand. These organizations are employing strategies like new product releases, partnerships, collaborations, mergers, and acquisitions to gain a competitive advantage.

More Insights into Coronary Stents Market Report

In its latest report, FMI offers an unbiased analysis of the global coronary stents market, providing historical data from 2016 to 2021 and forecast statistics for 2022 to 2032. To understand the global market potential, growth, and scope, the market is segmented based on product type (drug-eluting stent (DES), bare metal stent (BMS), bioresorbable vascular stent (BVS)), raw material (cobalt chromium, stainless steel, platinum-chromium, nickel-titanium, polymer), end user (hospitals, ambulatory surgical centers, cardiac catheterization laboratories), and region.

According to the latest FMI reports, based on region, China’s coronary stent market will likely exhibit an impressive growth rate during the observation period due to favorable government support for the healthcare sector. The coronary stent market in the United States is anticipated to demonstrate substantial growth over the forecast period. The rising prevalence of coronary artery disease is spurring the demand for interventional cardiology treatment in this country. Sedentary lifestyles, smoking, poor dietary habits, and pollution often contribute to increasing cases of cardiovascular diseases. All of these factors are expected to drive the demand for the target market during 2022-2032.

Key Segments Covered in the Coronary Stents Market Analysis

By Product:

Drug Eluting Stent (DES)
Bare Metal Stent (BMS)
Bioresorbable Vascular Stent (BVS)

By Raw Material:

Cobalt-Chromium
Stainless Steel
Platinum – Chromium
Nickel – Titanium
Polymer

By End User:

Hospitals
Ambulatory Surgical Centers
Cardiac Catheterization Laboratories

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI is the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Artificial Intelligence Systems Spending Soars: Market Set to Reach US$ 516.2 Billion by 2027

The global “artificial intelligence systems spending market” is anticipated to soar with a staggering 46.1% CAGR throughout the projection period between 2017 and 2027. The coronavirus pandemic benefits from the coronavirus outbreak as businesses are remodelling operations to allow employees to work from home. Further, increased spending on online communications and cloud technologies will generate lucrative opportunities during the pandemic.

Artificial Intelligence Systems Spending Market – Key Takeaways

Banking solutions for artificial intelligence systems are gaining strong demand, owing to automated customer service, and fraud analysis applications.
Pharmaceutical research applications are likely to witness rapid growth aided by the recent spurt in growth of digital patient and formulation databases.
Asia Pacific is displaying major growth in artificial intelligence system spending, supported by investments in hardware and infrastructure for artificial intelligence development.

Artificial Intelligence Systems Spending Market – Critical Driving Factors

Growing use of artificial intelligence in ERP and manufacturing solutions and applications drive adoption rates.
Sustained automated transport and logistics investments are a key factor contributing to revenues.
Artificial Intelligence Systems Spending Market – Major Constraints

Lack of adequate infrastructure to handle vast databases, setup processes, and manage workforce remains a key challenge to market players.
High capital required for artificial intelligence system development holds back market growth.
The Anticipated Impact of Coronavirus

The covid-19 pandemic is likely to benefit the artificial intelligence systems spending market. This can be attributed to high investments in cloud and internet infrastructure, for remote working operations around the world during the pandemic. Centralization of corporate data during the crisis will help companies to build on AI capabilities.

AI systems are being used to identify and track vulnerable populations, and generate warnings for potential outbreaks in the future. Further, these systems are proving useful in administration applications in healthcare facilities. Also, increased use of online shopping. However, concerns over privacy, bias and job loss will limit gains during this period.

Competition Landscape

Prominent developers in the artificial intelligence systems spending market include but are not limited to IPsoft Inc., Google Inc., Salesforce.com Inc., Microsoft Corp., Wipro Ltd., Facebook Inc., Infosys Ltd., IBM Corp., Intel Corp., Apple Inc., and Amazon.com Inc.

Artificial intelligence systems spending market players are widely investing in strategic acquisitions to bolster their AI capabilities, and expertise in AI development workforce.

For instance, in early 2020, Apple Inc., announced the acquisition of Xnor.ai for AI-based image recognition tools. Further Amazon has announced the acquisition of Zoox, a startup focused on AI-based autonomous driving developments. Similarly, Snap has revealed its acquisition of Ukraine-based AI-Factory for developing augmented reality functionalities.

Market Taxonomy

By Industry Type :

-BFSI
-Discrete & Process Manufacturing
-Healthcare
-Retail
-Wholesale
-Professional & Consumer
-Service
-Transportation

By Technology :

-Deep Learning
-Machine Learning
-Natural Language Processing
-Machine Vision
-AGI
-ASI

By Market :

-Hardware
-Software
-Services

By Region :

-North America
-Asia-Pacific excluding
-Japan
-Western Europe
-Eastern Europe
-Latin America
-Middle East and Africa
-Japan

About Future Market Insights (FMI)

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Syringes and Needles Market in GCC Projected to Reach USD 1,164.90 Million by 2034 at a 5.40% of CAGR

Future Market Insights reveals that the syringes and needles market in the Gulf Cooperation Council (GCC) region is on an upward trajectory. Sales are expected to rise at a compound annual growth rate (CAGR) of 5.40% through 2034. The market is projected to surpass USD 688.5 million in 2024 and reach an estimated valuation of USD 1,164.90 million by 2034.

This growth reflects increasing healthcare demands and advancements in medical technology within the GCC region. The rising prevalence of chronic diseases, coupled with an expanding healthcare infrastructure, is driving the need for syringes and needles.

This robust growth is driven by increasing healthcare needs, rising patient volumes, and the expanding use of syringes and needles in various medical procedures. The demand for these essential medical supplies is fueled by advancements in healthcare infrastructure and a heightened focus on effective and safe medical treatments.

Digital Dentistry: The Future

In the year 2019, the IDC (International Dental Show) was attended by the Institute of Digital Dentistry in Cologne, Germany. It threw light on the ways dentistry has evolved in the form of 3D printers, CAD materials, milling machines, and intraoral scanners. The institute otherwise provides training and CAD/CAM courses in New Zealand as well as online to keep the dentists and course attendees updated about clinical relevance and implementation of digitization by the key market players.

Digital Expansion: Key to Growth

As stated above, the market players are looking to provide digital imaging solutions to cater to the increasing number of patients with dental ailments. Some of the measures taken in this regard include:

In Jun 2020, Level Equity-backed Planet DDS signed an agreement to acquire Apteryx Imaging, a Canada-based publicly traded company to explore a wider arena in terms of geography
DENTSPLY Sirona Inc., in Oct 2019, launched 2 intraoral sensors (Xios AE and Schick AE) and 3D/2D imaging systems (Orthophos E, Orthophos SL 3D, and Orthophos S 3D)
In Oct 2019, Envista Holdings Corporation entered into a partnership with TeamSmile programs all through the US for propagating the use of KaVo SMARTmatic and KaVo MASTERtorque LUX M8900L

Key Takeaways of Dental Imaging Equipment Market

The market is expected to grow steadily, reaching a value of USD 4.45 billion by 2034.
Increased focus on oral health and preventive care is driving demand for dental imaging equipment.
Patients are seeking earlier diagnosis and treatment, prompting dental practices to invest in advanced imaging technology.
Manufacturers are innovating with touchless features, remote operation, and improved disinfection to meet post-pandemic needs.

“The players are shifting their gears towards digital imaging. This upgradation is expected to shape the Global Dental Imaging Equipment Industry.” says an FMI Analyst.

More Valuable Insights on Dental Imaging Equipment Market

Future Market Insights brings a comprehensive research report on forecasted revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the segments from 2015 to 2030. The Global Dental Imaging Equipment Industry is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader. The study provides compelling insights into the dental imaging equipment market based on product type, (Intraoral X-ray Systems, Intraoral Plate Scanners, Intraoral Sensors, Intraoral Phosphor Storage Plates, Extraoral X-ray Systems, Cone-Beam Computed Tomography (CBCT) Imaging, Intraoral Cameras), by End User (Hospitals, Ambulatory Surgical Centers, Independent Dental Clinics, Forensic Laboratories), across seven major regions.

Leading Players in the Dental Imaging Equipment Market

The dental imaging equipment market is onto the digital spree. Digital imaging systems are being provided by the key players to cater to the increasing number of patients throughout. At the same time, AI is being tried out as an effective tool for dental digital solutions.

In line with the above-mentioned developments, twin robotic X-Ray system from Siemens provides a combination of 2D X-Rays with fluoroscopy along with 3D imaging.

The key players in dental imaging equipment including the ones mentioned above are:

Envista Holdings Corporation
Dentsply Sirona
Carestream Dental, LLC
Danaher Corporation
Acteon Group
Planmeca Oy

Dental Imaging Equipment Market: Segmentation The Global Dental Imaging Equipment Industry is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader. Product Type

Intraoral X-ray Systems
- Wall/Floor Mounted Intraoral X-ray Systems
- Hand-Held Intraoral X-ray Systems
Intraoral Plate Scanner
Intraoral Sensors
Intraoral Phosphor Storage Plates
Extraoral X-ray Systems
- Panoramic X-rays Systems
- Cephalometric Projections Systems
Cone-Beam Computed Tomography (CBCT) Imaging
Intraoral Cameras

End Users

Hospitals
Independent Dental Clinics
Ambulatory Surgical Centres
Forensic Laboratories

A Full Report – Overview

Key Segments :

By Product:

Oral
Hypodermic
- Standard
- Special Purpose
  - Insulin
  - Tuberculin
  - Other Special Purpose
  - Angiographic

By Usability:

Disposable
Reusable

By Material:

Glass
Polymer

By End User:

Hospital
Blood Collection Center
Diabetic Care Center
Veterinary Care Center
Others

By Country:

Kingdom of Saudi Arabia (KSA)
United Arab Emirates (UAE)
Qatar
Bahrain
Oman
Kuwait

Author

Identifying key challenges clients face and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Dental Imaging Equipment Market Size Reach USD 4,450.8 Million by 2034 at a 3.30% of CAGR

The global Dental Imaging Equipment Market is flashing a healthy smile, experiencing robust growth fueled by a surge in oral health awareness. According to market projections, the market is set to skyrocket from USD 3,216.9 million in 2024 to a staggering USD 4,450.8 million by 2034, reflecting a Compound Annual Growth Rate (CAGR) of 3.30%.

Digital Dentistry: The Future

Digital Expansion: Key to Growth

In Jun 2020, Level Equity-backed Planet DDS signed an agreement to acquire Apteryx Imaging, a Canada-based publicly traded company to explore a wider arena in terms of geography
DENTSPLY Sirona Inc., in Oct 2019, launched 2 intraoral sensors (Xios AE and Schick AE) and 3D/2D imaging systems (Orthophos E, Orthophos SL 3D, and Orthophos S 3D)
In Oct 2019, Envista Holdings Corporation entered into a partnership with TeamSmile programs all through the US for propagating the use of KaVo SMARTmatic and KaVo MASTERtorque LUX M8900L

Key Takeaways of Dental Imaging Equipment Market

The market is expected to grow steadily, reaching a value of USD 4.45 billion by 2034.
Increased focus on oral health and preventive care is driving demand for dental imaging equipment.
Patients are seeking earlier diagnosis and treatment, prompting dental practices to invest in advanced imaging technology.
Manufacturers are innovating with touchless features, remote operation, and improved disinfection to meet post-pandemic needs.

“The players are shifting their gears towards digital imaging. This upgradation is expected to shape the Global Dental Imaging Equipment Industry.” says an FMI Analyst.

More Valuable Insights on Dental Imaging Equipment Market

Leading Players in the Dental Imaging Equipment Market

In line with the above-mentioned developments, twin robotic X-Ray system from Siemens provides a combination of 2D X-Rays with fluoroscopy along with 3D imaging.

The key players in dental imaging equipment including the ones mentioned above are:

Envista Holdings Corporation
Dentsply Sirona
Carestream Dental, LLC
Danaher Corporation
Acteon Group
Planmeca Oy

*The list is not exhaustive and is only for representational purposes. Full competitive intelligence with SWOT analysis is available in the report

Intraoral X-ray Systems
- Wall/Floor Mounted Intraoral X-ray Systems
- Hand-Held Intraoral X-ray Systems
Intraoral Plate Scanner
Intraoral Sensors
Intraoral Phosphor Storage Plates
Extraoral X-ray Systems
- Panoramic X-rays Systems
- Cephalometric Projections Systems
Cone-Beam Computed Tomography (CBCT) Imaging
Intraoral Cameras

End Users

Hospitals
Independent Dental Clinics
Ambulatory Surgical Centres
Forensic Laboratories

Author

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Regenerative Medicine Industry Set for Remarkable Growth, Projected to Reach USD 73,084.2 Million by 2033 at a 18.5% of CAGR

The Global Regenerative Medicine Industry is on track for a remarkable trajectory, with a projected market value of USD 73,084.2 million by 2033. This signifies a staggering growth rate, with the market estimated to be valued at USD 13,385.6 million in 2023. This translates to a Compound Annual Growth Rate (CAGR) of approximately 18.5% anticipated from 2023 to 2033.

Over the projection period, there will be a greater need for the regenerative medicine industry due to the global increase in the incidence and prevalence of chronic diseases like cancer, diabetes, ulcers, and cardiovascular disease.

Increasing awareness about regenerative medicines and increasing the ability of people to spend on better treatments are playing a key role in promoting the growth of the industry. The growing aging population and increased demand for regenerative medicine in treating age-related degenerative diseases are driving growth in the industry.

An increase in investment by government organizations in the development of regenerative medicine is a major factor boosting the growth of the global industry during the forecast period. The increasing demand for personalized medicines has led to the development of patient-specific therapies, driving demand in the market.

The growing technological advances in stem cell research, tissue engineering, 3D bioprinting, and gene therapy have expanded the possibilities within regenerative medicine. These technologies enable the development of more effective and targeted treatments, attracting investment and driving innovation in the field.

The rising incidences of genetic disorders such as cystic fibrosis and other rare disorders propel the growth of the regenerative medicine market, as these therapies have the potential to address the root causes of rare genetic and inherited disorders.

Global Regenerative Medicine Industry Key Takeaways:

From 2017 to 2022, the regenerative medicine industry was valued at a CAGR of 16.2%
Based on therapy type, tissue engineering segment is expected to account for a share of 43% in 2023.
Global regenerative medicine demand in Australia is predicted to account for a CAGR of 11.5% through 2033.
In the United Kingdom regenerative medicine industry is expected to account for a CAGR of 13.2% between 2023 and 2033.
China is projected to expand by a value CAGR of 27.2% between 2023 and 2033.
By 2033, the regenerative medicine industry in India is anticipated to record a CAGR of 15.5% during the forecast period.

“The increasing awareness of consumers, growing prevalence of chronic diseases, and rising needs for personalized medicine solutions are anticipated to drive the industry growth during the forecast period,” opines Sabyasachi Ghosh, Associate Vice President at Future Market Insights (FMI) analyst.

Competitive Landscape from the Global Regenerative Medicine Industry:

The global regenerative medicine industry is highly fragmented due to the presence of several international as well as regional players. Key players in the global industry of regenerative medicine are engaged in regulatory approvals, technologically advanced products, the launch of new products, and acquisition & collaborative agreements with other companies.

In February 2020, Stryker Corporation acquired Wright Medical to expand its product portfolio.
In October 2020, Thermo Fisher Scientific, Inc. launched the Gibco CTS Rotea Counterflow Centrifugation System, a closed cell therapy processing system for developing and manufacturing scalable and cost-effective cell therapy.
Roche has invested in regenerative medicine through its subsidiary Genentech. They have been involved in stem cell research and regenerative approaches for neurological disorders. The company is exploring personalized medicine options using regenerative techniques.

Global Regenerative Medicine Industry Segmentation:

By Therapy type:

Cell Therapy
- Autologous Cell Therapy
- Allogenic Cell Therapy
Stem Cell Therapy
- Allogeneic Stem Cell Therapy
- Autologous Stem Cell Therapy
Tissue-engineering
Gene Therapy

By Application:

Wound Care
Musculoskeletal
Oncology
Dental
DMD (Duchenne Muscular Dystrophy)
Hepatological Diseases
Inflammatory & Autoimmune Diseases
Other Therapeutic Applications

Author By:

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Antibody Market to Reach USD 581.42 Billion by 2034 with a 8.1% of CAGR

Future Market Insights forecasts substantial growth for the global antibody market, which is expected to be valued at approximately USD 266.83 billion in 2024. The market is projected to expand at a robust compound annual growth rate (CAGR) of 8.1% from 2024 to 2034, with an anticipated market size of USD 581.42 billion by the end of the forecast period.

This significant growth translates to an absolute dollar increase of USD 315 billion, reflecting the escalating demand for antibodies across various therapeutic areas. The expansion is driven by advancements in antibody research and development, increasing prevalence of chronic diseases, and a growing emphasis on personalized medicine.

Advancements in biotechnology, an increase in the prevalence of chronic illnesses, and the rising demand for targeted therapies are key factors propelling the antibody market forward. Additionally, significant investments in research and development are leading to the innovation of new and more effective antibody-based treatments, further fueling market growth.

Antibodies are vital in the domains of medicine, pharmacology, research applications, and diagnostics. This is shown by the market’s expected growth. As an essential component of the immune system’s fight against infections, antibodies—also referred to as immunoglobulins—help prevent infectious diseases, autoimmune illnesses, and cancer.

Focus on High-Quality and Specificity

As research becomes increasingly sophisticated, the need for high-quality and highly specific research antibodies becomes paramount. This ensures accurate and reliable results, ultimately contributing to breakthroughs in scientific exploration and medical advancements.

Proteomics, genomics, and biotechnology developments have propelled the market’s substantial expansion for research antibodies. There are several different types of antibodies available on the market, such as recombinant, polyclonal, and monoclonal antibodies, all of which are designed to target different biomarkers and antigens. These antibodies are used by researchers in academic institutions, pharmaceutical companies, and biotechnology businesses to decipher intricate biological processes, identify disease pathways, and confirm possible therapeutic targets.

Key Takeaways: Research Antibodies Market:

The research antibodies market plays a pivotal role in advancing scientific discoveries and medical breakthroughs across various fields of study. Here are the key takeaways that highlight the trends, challenges, and opportunities within the research antibodies market:

Market Growth and Importance:
- The research antibodies market is witnessing significant growth due to increasing demand for targeted and personalized medicine, as well as the expansion of life sciences research.
- Research antibodies are crucial tools for identifying and studying specific proteins, biomarkers, and cellular components, enabling researchers to unravel complex biological processes.
Monoclonal vs. Polyclonal Antibodies:
- Monoclonal antibodies (mAbs) offer high specificity and consistency, making them preferred choices for diagnostic and therapeutic applications.
- Polyclonal antibodies (pAbs) have broader binding capabilities and are often used for detecting multiple epitopes.
Application Diversity:
- Research antibodies find applications in various domains, including cancer research, neuroscience, immunology, stem cell research, and infectious diseases.
- They aid in studying disease mechanisms, validating drug targets, and monitoring treatment responses.
Technological Advancements:
- The development of recombinant antibody technologies has led to the generation of recombinant antibodies with improved specificity and reduced batch-to-batch variability.
- Single-cell antibody sequencing and phage display techniques are enhancing antibody discovery and customization.
Quality and Reproducibility Concerns:
- Ensuring antibody specificity, reproducibility, and validation has been a challenge, leading to concerns about irreproducible results in research.
- Initiatives like the “Reproducibility Crisis” movement emphasize the importance of transparent reporting and validation of research antibodies.
Rising Industry Regulations:
- Regulatory bodies are emphasizing the need for rigorous validation of research antibodies to ensure reliable and accurate experimental outcomes.
- Guidelines for antibody validation, such as those provided by the International Working Group on Antibody Validation (IWGAV), are gaining traction.

Key Companies Profiled:

Abcam Plc
Agilent Technologies
Bio-rad Laboratories
Becton Dickinson & Company
Cell Signalling Technology, Inc.
F. Hoffmann La Roche Ltd.
Lonza Group
Merck Millipore
Perkinelmer Inc.
Thermo Fisher Scientific, Inc.

A Full Report – Overview

Market Segments Covered in Research Antibodies Market Analysis:

By Product Type:

Primary
Secondary

By Type:

Monoclonal Antibodies
Polyclonal Antibodies

By Technology:

Immunohistochemistry
Immunofluorescence
Western Blotting
Flow Cytometry
Immunoprecipitation
ELISA
Other Technologies

By Source:

Mouse
Rabbit
Goat
Other Sources

By Region:

North America
Latin America
Europe
APAC
MEA

About Future Market Insights (FMI)

Contact Us:

XYZ 2022 Future Analysis, Demand by Regions and Opportunities with Challenges 2032

The global wearable fitness tracker market is anticipated to reach a valuation of US$ 30,922.1 million in 2024, driven by incorporation of AI and ML. The trend is expected to create new opportunities for the market, leading to a projected CAGR of 15.7% between 2024 and 2034, and reaching a total valuation of approximately US$ 133,218.4 million by 2034.

One of the major factors contributing to the growth of the market is the subscription based models, which are adopted by some companies, where users pay for advanced features, premium content, or extended services within the fitness tracker ecosystem.

The establishment of regulatory standards for health and fitness wearables can provide a level of assurance for consumers regarding the accuracy and reliability of these devices. Regulatory support can also drive innovation and market growth by creating a more stable and trustworthy environment.

There is a growing interest in integrating continuous blood glucose monitoring into wearable fitness trackers. The feature can be particularly valuable for individuals with diabetes or those looking to monitor their glucose levels for overall health and fitness management.

Wearable fitness trackers with enhanced sleep tracking features are gaining popularity. Devices that not only monitor sleep patterns but also provide insights and suggestions for improving sleep quality are becoming more prevalent.

The integration of wearable fitness trackers with virtual assistants, such as Siri, Google Assistant, or Alexa, allows users to access information, set reminders, and control other smart devices using their fitness tracker. The trend adds a layer of convenience and functionality.

The rise of telehealth services presents an opportunity for wearable fitness trackers to integrate seamlessly with virtual healthcare platforms. The integration can enable users to share their health data with healthcare professionals for remote consultations and monitoring.

Key Takeaways from the Market Study

Global wearable fitness tracker market was valued at US$ 26,787.8 million by 2023-end.
From 2019 to 2023, the market demand expanded at a CAGR of 14.6%.
The market in India is expected to expand at a CAGR of 16.7% through 2034.
By product type, the wrist wear segment to account for a share of 43.4% in 2024.
From 2024 to 2034, wearable fitness tracker market is expected to flourish at a CAGR of 15.7%.
By 2034, the market value of wearable fitness tracker is expected to reach US$ 133,218.4 million.

Some manufacturers are exploring modular designs that allow users to upgrade specific components of their fitness trackers, such as sensors or display modules. The approach promotes longevity and reduces electronic waste, remarks an FMI analyst.

Competitive Landscape

Prominent players in the wearable fitness tracker market are Apple Inc., Fitbit Inc., Samsung Electronics, Sony Corporation, Xiaomi, Garmin Ltd., Fossil Group, Jawbone, TomTom International BV, and Huawei Technologies Co., Ltd., among others.

Recent Developments

In 2023, Huawei announced the launch of its new Huawei Watch GT 3 Pro, which features a new 30 day battery life and a new ECG app for detecting atrial fibrillation.
In 2022, Apple announced the launch of its new Apple Watch Series 7, which features a new larger display and a new fast charging feature.
In 2022, Samsung announced the launch of its new Galaxy Watch 4, which features a new Wear OS operating system and a new body composition analysis feature.

In the same year, Fitbit announced the launch of its new Fitbit Charge 5, which features a new stress management score and a new ECG app for detecting atrial fibrillation.

Key Companies Profiled

Apple Inc.
Fitbit Inc.
Samsung Electronics
Sony Corporation
Xiaomi
Garmin Ltd.
Fossil Group
Jawbone
TomTom International BV
Huawei Technologies Co., Ltd.

Elevate Your Business Strategy! Purchase the Report for Market-Driven Insights

More Valuable Insights Available

Future Market Insights offers an unbiased analysis of the global wearable fitness tracker market, providing historical data for 2019 to 2023 and forecast statistics from 2024 to 2034.

To understand opportunities in the wearable fitness tracker market, the market is segmented on the basis of product type (wrist wear, leg wear, smart garments, and others), application (pedometer, heart rate monitor, daily activity tracker, call text and calendar, sleep tracking, GPS tracking, and others), distribution channel (e-commerce, and retail stores), and age group (0 to 5 years, 6 to 18 years, 19 to 24 years, 25 to 44 years, 45 to 60 years, and 60+ years), across seven major regions (North America, Latin America, Western Europe, Eastern Europe, South Asia & Pacific, East Asia, and Middle East & Africa (MEA)).

Segmentation Analysis of the Wearable Fitness Tracker Market

By Product Type:

Wrist Wear
Leg Wear
Smart Garments
Others

By Application:

Pedometer
Heart Rate Monitor
Daily Activity Tracker
Call Text and Calendar
Sleep Tracking
GPS Tracking
Others

By Distribution Channel:

E-Commerce
Retail Stores

By Age Group:

0 to 5 Years
6 to 18 Years
19 to 24 Years
25 to 44 Years
45 to 60 Years
60+ Years

By Region:

North America
Latin America
Western Europe
Eastern Europe
South Asia & Pacific
East Asia
The Middle East & Africa

About Future Market Insights (FMI)

Contact Us: